Related Experiment Video
Updated: Feb 10, 2026

Fabricating Cotton Analytical Devices
Published on: August 30, 2016
Analytical validation of a psychiatric pharmacogenomic test
Michael R Jablonski1, Nina King1, Yongbao Wang1
1Assurex Health, Inc., Mason, OH, USA.
Aim:
The aim of this study was to validate the analytical performance of a combinatorial pharmacogenomics test designed to aid in the appropriate medication selection for neuropsychiatric conditions.
Materials & Methods:
Genomic DNA was isolated from buccal swabs. Twelve genes (65 variants/alleles) associated with psychotropic medication metabolism, side effects, and mechanisms of actions were evaluated by bead array, MALDI-TOF mass spectrometry, and/or capillary electrophoresis methods (GeneSight Psychotropic, Assurex Health, Inc.).
Results:
The combinatorial pharmacogenomics test has a dynamic range of 2.5-20 ng/μl of input genomic DNA, with comparable performance for all assays included in the test. Both the precision and accuracy of the test were >99.9%, with individual gene components between 99.4 and 100%.
Conclusion:
This study demonstrates that the combinatorial pharmacogenomics test is robust and reproducible, making it suitable for clinical use.
Related Concept Videos
Reliability and Validity
Development of Analytical Methods
Data Validation
Key parameters for method validation include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Analyte Adsorption and Distribution
Jung's Analytical Theory

